Abstract An efficient method for the synthesis of a novel series of cyclopenta [b]pyrano pyrimidinone derivatives with silica-bonded N-propyl diethylenetriamine sulfamic acid (SBPDSA) as catalyst has been achieved by the condensation of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta [b]pyran-3-carbonitrile derivatives and coumarin-3-carboxylic acid under solvent free conditions. Antimicrobial studies showed all the target compounds processing good antibacterial and antifungal activities. 
Introduction
Coumarins (2-oxo-2H-chromenes) are an old class of compounds, also known as benzopyranes, comprising a large class of cinnamic acid-derived phenolic compounds found in fungi, bacteria and plants, particularly in edible plants from different botanical families. Coumarins and their derivatives have attracted intense interest in recent years because of their diverse pharmacological properties such as anti-inflammatory (Witaicenis et al., 2014) , antitumor (Avin et al., 2014) , anticancer (Jashari et al., 2014; Zhang et al., 2014) , acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors (Asadipour et al., 2013) , anti-proliferative (Zhao et al., 2014) , antibacterial, antifungal and antioxidant (Renuka and Kumar, 2013) , anti-osteoporotic (Sashidhara et al., 2013) and anti-tuberculosis activities (Kawate et al., 2013) .
A considerable effort has been made for the synthesis of heterocyclic compounds containing coumarin moiety due to their wide pharmaceutical importance (Banothu and Bavanthula, 2012; Ghosh and Das, 2012; Augustine et al., 2012; Khoobi et al., 2011; Khan et al., 2011 Khan et al., , 2012 Khurana and Kumar, 2009 ). However, these procedures are not entirely satisfactory and suffer from long reaction time or tedious work up. Hence, a method using a nonmetallic catalyst is desirable. Therefore, the introduction of new and efficient methods for this reaction is still necessary. Toward this goal, we were prompted to explore new methods for the synthesis of heterocyclic compounds containing coumarin moiety.
Silica-bonded N-propyl diethylenetriamine sulfamic acid has been reported as a novel catalyst for chemoselective synthesis of 1,1-diacetates (Sefat et al., 2011) , and synthesis of a-aminonitriles (Rahi et al., 2012) . However, to the best of our knowledge, there are no examples on the use of SBPDSA as catalyst for the synthesis of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-aryl-cyclopenta [b] pyrano-pyrimidine-4,6-5H-dione derivatives.
Considering the potential of developing new routes to the synthesis of heterocyclic compounds containing coumarin moiety due to their wide pharmaceutical importance (Ghashang et al., 2013 (Ghashang et al., , 2014a , we now describe the synthesis of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl-cyclopenta [b] pyrano-pyrimidine-4,6-5H-dione derivatives by the condensation of 2-amino-4-phenyl-5-oxo-4, 5,6,7-tetrahydrocyclopenta[b] pyran-3-carbonitrile derivatives and coumarin-3-carboxylic acid using SBPDSA as an efficient novel catalyst.
The synthesis of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta [b] pyran-3-carbonitrile derivatives was achieved by the condensation of aldehydes 1, malononitrile 2 and cyclopentane-1,3-dione 3, using Alum (KAl(SO 4 ) 2 AE12H 2 O) as catalyst under solvent-free conditions (Scheme 1).
Experimental

Apparatus and analysis
Chemicals were purchased from Merck, Fluka and Aldrich Chemical Companies. All yields refer to isolated products unless otherwise stated. 1 H NMR (500 MHz) and 13 C NMR (125 MHz) spectra were obtained using a Bruker DRX-500 Avance spectrometer at ambient temperature, using TMS as internal standard. FT-IR spectra were recorded as KBr pellets on a Shimadzu spectrometer. Mass spectra were determined on a Varian-Saturn 2000 GC/MS instrument. Elemental analysis was measured by means of a Perkin Elmer 2400 CHN elemental analyzer flowchart.
Preparation of silica-bonded N-propyl diethylenetriamine sulfamic acid (SBPDSA)
The catalyst was prepared as per the previously reported method (Sefat et al., 2011) . The catalyst SBPDSA was obtained as a white powder. The content of S obtained from elemental analysis showed that typically a loading of 0.99 mmol/g H + was obtained (Rahi et al., 2012 26.0, 35.2, 39.0, 49.2, 58.3, 112.0, 119.4, 126.3, 127.3, 129.0, 144.0, 157.9, 163.0, 195.6 26.7, 35.3, 38.7, 49.4, 58.0, 112.6, 119.2, 126.4, 127.3, 129.3, 143.7, 158.3, 162.9, 196.0 26.4, 35.4, 39.4, 49.1, 57.9, 113.0, 118.9, 125.9, 127.3, 128.9, 143.8, 158.5, 163.8, 196. 27.0, 36.0, 38.7, 49.7, 58.6, 113.2, 118.8, 126.3, 127.3, 128.7, 144.4, 158.8, 164.0, 195.9 26.8, 36.1, 39.4, 49.4, 58.6, 112.8, 119.4, 126.5, 127.3, 128.4, 144.0, 158.6, 163.6, 196 35.7, 38.6, 50.0, 59.0, 113.4, 118.8, 125.7, 127.3, 129.0, 143.6, 158.4, 163.8, 195. ): 3466, 3401, 3333, 3289, 2194, 1677, 1596, 1525, 1358, 1074, 844 26.5, 36.1, 39.3, 50.2, 58.4, 112.7, 118.7, 126.7, 127.3, 129.2, 144.2, 158.4, 163.0, 196. ): 3398, 3320, 3210, 2199, 1672, 1604, 1516, 1364, 1033, 855 37.3, 38.6, 49.6, 59.2, 112.9, 118.7, 126.3, 127.3, 129.3, 144.5, 158.0, 163.4, 196 35.7, 38.3, 50.2, 58.3, 112.9, 118.9, 125.8, 127.3, 128.8, 143.8, 157.9, 163.6, 196.0 27.4, 36.4, 38.7, 49.7, 59.3, 113.5, 118.2, 125.6, 127.3, 129.4, 144.0, 158.2, 163.7, 195.8 
General procedure to synthesis of
pyrano-pyrimidine-4,6-5H-dione derivatives using SBPDSA as catalyst A mixture of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta [b] pyran-3-carbonitrile 4a-j (1 mmol), coumarin-3-carboxylic acid 5 (1 mmol) and SBPDSA (0.051 g/5 mol%) was heated at 80°C for about 4-6 h (Scheme 2). After completion of the reaction (TLC), 2 mL of water was added, and the reaction mixture was stirred at room temperature for 20 min. The resulting precipitate was filtered. The crude product was purified by column chromatography (n-hexane/ethyl acetate, 80:20) to provide the pure products. Compounds 6a-j were identified by IR, 1 H NMR, 13 C NMR, mass and elemental analysis.
2.6. Spectral data for the synthesized compounds (6a-j) 16.5, 20.3, 26.7, 35.9, 37.2, 100.0, 113.2, 115.9, 118.2, 118.9, 124.9, 129.3, 131.0, 134.0, 136.5, 152.5, 154.6, 156.9, 164.7, 195.4 20.4, 26.5, 35.7, 36.9, 101.0, 113.8, 115.7, 117.9, 118.4, 124.3, 129.3, 130.5, 134.2, 137.0, 153.0, 154.0, 157.1, 163.9, 194.9 16.6, 20.3, 26.6, 36.2, 37.2, 100.2, 113.1, 116.4, 118.4, 118.9, 124.9, 129.3, 130.3, 134.3, 136.4, 153.1, 154.0, 156.3, 163.5, 194.5 20.4, 26.0, 36.3, 37.1, 100.4, 113.6, 116.0, 118.4, 119.0, 124.8, 129.3, 131.0, 134.2, 136.4, 152.8, 153.8, 156.8, 163.8, 194.9 20.0, 26.2, 35.9, 37.7, 101.3, 113.9, 115.7, 118.2, 118.8, 124.8, 129.3, 130.7, 133.8, 137.0, 153.4, 154.1, 156.7, 164.4, 195.4 16.4, 20.3, 26.1, 36.4, 38.0, 100.5, 113.4, 116.3, 118.2, 118.6, 124.6, 129.3, 130.7, 134.4, 136.4 124. 7, 129.3, 131.2, 134.3, 136.3, 152.8, 153.9, 156.8, 164.3, 194.6 16.3, 20.2, 26.3, 35.7, 37.0, 101.2, 114.2, 116.0, 118.3, 118.8, 125.0, 129.3, 131.4, 134.2, 136.4, 152.8, 153.8, 157.4, 166.0, 196.0 
Results and discussion
The synthetic pathway of compounds (6a-j) was achieved via the intermediates 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta [b] pyran-3-carbonitrile derivatives (4a-j). These compounds (4a-j) were obtained by the three component condensation of aldehydes 1, malononitrile 2 and cyclopentane-1,3-dione 3 using Alum (KAl(SO 4 ) 2 AE12H 2 O) (10 mol%), under solvent-free conditions (Scheme 1). Due to its mild and reusable catalytic activity for the synthesis of pyran derivatives (Rajguru et al., 2013) , we opted to use Alum [KAl(SO 4 ) 2 AE12H 2 O] as a non-toxic catalyst. The aromatic aldehydes 1 bearing electron-withdrawing and electron donating groups were found to be equally effective to produce 2-amino-4H-pyrans 4a-j in very good yields (Table 1) .
After the synthesis of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta[b]pyran-3-carbonitrile derivatives 4, we have synthesized compounds 6. To optimize the reaction conditions, the effect of catalyst loading was investigated between compound 4a and coumarin-3-carboxylic acid. The reaction was carried out under neat conditions at 80°C without and with different acid catalysts (cellulose sulfuric acid, silica sulfuric acid, sulfamic acid, SBPDSA each 5 mol%). The maximum yield was obtained using SBPDSA. It can be seen that the reaction did not proceed even after 12 h in the absence of this catalyst (Table 2, entry 1). Although a lower catalyst loading of 3 or 2 mol% accomplished this condensation, 5 mol% of SBPDSA was optimal in terms of reaction time and isolated yield (Table 2, entries 5 and 6). Increasing the amount from 5 to 8 mol% has no effect on the product yield and reaction time (Table 2, entry 8).
To expand the generality of this novel catalytic method, various cyclopenta[b]pyrano pyrimidinone derivatives 6a-j (Scheme 2) were synthesized under the optimized conditions and the results are presented in Table 3 . After completion of the reaction the catalyst, SBPDSA was recovered by evaporating the aqueous layer, washed with acetone, dried and reused for subsequent reactions without significant loss in its activity (Fig. 1) . All the structures of the synthesized compounds 6 were confirmed by their analytical and spectroscopic data.
A probable mechanism for the formation of 6a as a model via the condensation reaction is outlined in Scheme 3. Firstly, the protonation of coumarin-3-carboxylic acid by SBPDSA as a solid acid occurred to form a cation intermediate (a). In continuation, the formation of (b) resulting from the amidation of (a) with 4a was established. In the next step, the protonation of nitrile group of intermediate (b) following by a cyclo-addition reaction occurred to form the intermediate (c). In continuation the addition reaction of -SO 3 À followed by ring opening of the (c) to the intermediate (d) and (e) followed by ring closure of intermediate (e) results in the formation of intermediate (f) that converts to the (6a) as product by the de-protonation reaction. Interestingly, the formation of compound 6a, obtained from the condensation of coumarin-3-carboxylic acid with 4a, confirms the mechanism of the reaction which was rarely described in the literature as Dimroth rearrangement (Foucourt et al., 2010; Dimroth, 1909) .
The possibility of recycling the catalyst was examined using the condensation reaction of compound 4a with coumarin-3-carboxylic acid 5 in the optimized conditions. The catalyst was recovered from the aqueous phase (filtration), washed with acetone, dried and re-used for subsequent reactions without loss of activity and efficiency. The recycled catalyst could be reused five times without any additional treatment or appreciable reduction in catalytic activity (Fig. 1) .
X-ray diffraction (XRD) for SBPDSA using powder X-ray diffraction measurements was performed using Advance diffractometer made by Bruker AXS company in Germany. Scans were taken with a 2h step size of 0.04 and a counting time of 30 s at room temperature. Specimens for XRD were prepared by compaction into a glass-backed aluminum sample holder. Data were collected over a 2h range from 4°to 75°. The fresh catalyst and recovered catalyst were characterized by XRD and their pattern is presented in Fig. 2 . As it is shown in Fig. 2 no significant change in the structure of catalyst was observed during the reaction.
Biological evaluations
Variously substituted on the aromatic ring, the compounds 6a-j may be useful in understanding the influence of steric and electronic effects on biological activity. They were tested for their antibacterial and antifungal activity at different concentrations in DMSO. Ciprofloxacin and Amphotericin-B were used as the positive control drugs for antibacterial and antifungal tests, respectively. Inoculums of the bacterial and fungal cultures were also prepared. The minimum concentration at which no growth was observed was taken as the minimum inhibitory concentration (MIC) value.
Antibacterial activity
The newly synthesized compounds were screened for their in vitro antibacterial activity against Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae bacterial strains by the serial plate dilution method. Serial dilutions of the drug in Muller Hinton broth were taken in tubes and their pH was adjusted to 5.0 using phosphate buffer. A standardized suspension of the test bacterium was inoculated and incubated for 16-18 h at 37°C. The MIC is the lowest concentration of the drug for which no growth is detected. The results are summarized in (Table 4) , it has been observed that all compounds were found to have antibacterial activity against E. coli, P. aeruginosa and K. pneumoniae, and Staphylococcus aureus when compared with the employed standard drug. 
Antifungal activity
Newly prepared compounds were also screened for their antifungal activity against Aspergillus flavus, Rhizopus schipperae and Aspergillus niger in DMSO by the serial plate dilution method. Sabourauds agar media were prepared by dissolving peptone (1 g), D-glucose (4 g) and agar (2 g) in distilled water (100 mL) and adjusting the pH to 5.7. Normal saline was used to make a suspension of sore of fungal strains for lawning. Activity of each compound was compared with Amphotericin-B as standard. The results are summarized in Table 4 .
The MIC values were evaluated at concentration range, 25-50 lg/mL. The results given in Table 4 show that all compounds exhibited antifungal activity with MIC against A. flavus, R. schipperae and A. niger compared with Amphotericin-B as standard drug.
Influence of aromatic substituents
The results suggest that the antibacterial and antifungal activities are markedly influenced by the aromatic substituents. Compound 6a without any substituent in the aryl moiety exhibits antibacterial activity in vitro at 150, 100 and 150 lg/ml against E. coli, P. aeruginosa and K. pneumonia respectively and also exhibits antifungal activity in vitro at 150, 150 and 150 lg/ml against A. flavus, R. schipperae and A. niger, respectively. Compounds 6c, 6d and 6e with electron-withdrawing substituents in the aromatic ring show greater antibacterial activity than the other compounds against all the tested organisms. Also, compounds 6c and 6d show greater antifungal activity than all the other compounds against all the tested organisms. À0.17) and N(CH 3 ) 2 (À0.205)] and the aromatic substituent in 6i also has negative value for the Hammett substituent constant r m [CH 3 (À0.069)]. The Hammett substituent constant r for the aromatic substituents in 6f and 6g is r m OH (+0.12) and r p OH (À0.37), respectively. Hence, 6f is more active than 6g.
Acute toxicity
The median lethal doses (LD 50 ) of the synthesized compounds 6a-j were determined in mice (Sztaricskai et al., 1999) . Groups of male adult mice, each of six animals, were injected i.p. with graded doses of each of the test compounds. The percentage of mortality in each group of animals was determined 24 h, after injection. Computation of LD 50 was processed by a graphical method. The LD 50 values for 6a-j were 20-30 times higher than its MIC.
Conclusions
We have developed a green and simple protocol for the synthesis of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione derivatives via the condensation of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocyclopenta[b]pyran-3-carbonitrile derivatives and coumarin-3-carboxylic acid using SBPDSA as an efficient novel catalyst. This procedure is a promising strategy and has advantages such as easy workup and eco-friendliness. It is expected that the present methodology will find application in organic synthesis. All the synthesized compounds were screened for their in vitro antimicrobial activity compared to the standard drug Ciprofloxacin and Amphotericin-B for antibacterial and antifungal activity respectively. 
